Authum Investment Acquires 90% Stake in Security Receipts Linked to Wind World India Debt

1 min read     Updated on 01 Oct 2025, 09:05 PM
scanx
Reviewed by
Radhika SahaniScanX News Team
whatsapptwittershare
Overview

Authum Investment & Infrastructure Limited (AIIL) has acquired a 90% stake in security receipts issued by Omkara PS 05/2025-26 Trust, which holds the debt of Wind World India Limited (WWIL). AIIL invested INR 11,025.00 million for 1,10,25,000 security receipts, each with a face value of INR 1,000.00. The transaction was completed on October 1, 2025. WWIL operates and maintains approximately 4,500 MW of windmills and owns 550 MW of wind power assets through its subsidiaries.

20878556

*this image is generated using AI for illustrative purposes only.

Authum Investment & Infrastructure Limited (AIIL) has made a significant move in the debt market by acquiring a 90% stake in security receipts issued by Omkara PS 05/2025-26 Trust. The trust, which acquired the debt of Wind World India Limited (WWIL) from National Asset Reconstruction Company Limited (NARCL), issued security receipts worth INR 12,250.00 million.

Transaction Details

AIIL invested INR 11,025.00 million to secure 1,10,25,000 security receipts, representing 90% of the total issuance. Each security receipt has a face value of INR 1,000.00. The transaction was completed on October 1, 2025, as disclosed by AIIL to the stock exchanges in compliance with SEBI regulations.

About Wind World India Limited

Wind World India Limited, the company whose debt is at the center of this transaction, is a significant player in the renewable energy sector:

  • Primary Business: Operation and maintenance services for windmills
  • Installed Base: Approximately 4,500 MW of windmills under management
  • Power Generation Assets: Owns and operates 550 MW of wind power assets through its subsidiaries

Strategic Implications

This acquisition by Authum Investment & Infrastructure Limited could potentially have several strategic implications:

  1. Diversification: AIIL is expanding its investment portfolio into the renewable energy sector.
  2. Asset Recovery: The company is positioning itself to potentially benefit from the recovery of Wind World India's debt.
  3. Green Energy Focus: This move aligns with the growing emphasis on renewable energy investments in India.

Regulatory Compliance

AIIL made the disclosure to the BSE (Bombay Stock Exchange) and NSE (National Stock Exchange) in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company emphasized that this disclosure was made in the interest of transparency for its shareholders and the market.

Market Impact

The substantial investment by AIIL in these security receipts could be viewed as a vote of confidence in the potential recovery and future prospects of Wind World India Limited's assets.

As the renewable energy sector continues to grow in importance, deals like this may become more common, with investors looking to capitalize on opportunities in the green energy space while also participating in debt resolution processes.

Authum Investment Acquires 3% Stake in Serovia Pharma for INR 300 Crores

1 min read     Updated on 16 Sept 2025, 06:34 PM
scanx
Reviewed by
Radhika SahaniScanX News Team
whatsapptwittershare
Overview

Authum Investment & Infrastructure Limited (AIIL) has signed an agreement to acquire a 3% stake in Serovia Pharma Private Limited for INR 300 crores. AIIL will subscribe to 18,95,053 Series B Compulsorily Convertible Preference Shares (CCPS) at INR 1,583.07 per share. The payment will be made in two equal installments. Serovia Pharma, incorporated in 2025, focuses on pharmaceutical product development and distribution globally. The deal is expected to complete by September 20, 2025, subject to approvals.

19573461

*this image is generated using AI for illustrative purposes only.

Authum Investment & Infrastructure Limited (AIIL) has announced a strategic move into the pharmaceutical sector by signing an investment agreement to acquire a 3% stake in Serovia Pharma Private Limited. The deal, valued at INR 300.00 crores, involves the subscription of compulsorily convertible preference shares (CCPS) in the newly formed pharmaceutical company.

Deal Structure

  • AIIL will subscribe to 18,95,053 Series B CCPS of Serovia Pharma
  • Each CCPS has a face value of INR 10.00 with a premium of INR 1,573.07
  • Total price per share: INR 1,583.07
  • Payment will be made in two equal installments of 50% each

About Serovia Pharma

  • Incorporated on July 19, 2025
  • Focuses on developing, manufacturing, and distributing pharmaceutical products globally
  • Plans to expand presence to Cyprus and the United States
  • Registered office: Cepha Block 1st Floor, Sy No, 152/6&154/6 Dorasni Palya, Bannerghatta Road, Bangalore - 560076, Karnataka, India

Transaction Details

  • Agreement signed on September 15, 2025
  • Expected completion date: September 20, 2025
  • Subject to pre-closing conditions, including board and shareholder approvals

Strategic Implications

Amit Dangi, Whole Time Director of Authum Investment & Infrastructure Limited, stated that this acquisition aligns with the company's portfolio diversification strategy. The investment targets sectors with stability and growth potential, aiming to create value for stakeholders and ensure a sustainable, profitable future for the company.

Regulatory Compliance

The transaction has been disclosed under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. AIIL has informed both the BSE and the National Stock Exchange of India Limited about this strategic investment.

More News on Authum Inv & Infr
Explore Other Articles